Changes of biomarkers with oral exposure to benzo(a)pyrene, phenanthrene and pyrene in rats

Journal of Veterinary Science

Volumn 8, Issue 4, 2007, Pages 361-368

  Hwan, Goo Kang ^a   Sang, Hee Jeong ^a   Myung, Haing Cho ^b   Joon, Hyoung Cho ^a  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Benzo(a)pyrene; Biomarker; PAHs; Phenanthrene; Pyrene

Indexed keywords

RATTUS;

EID: 37349045953     PISSN: 1229845X     EISSN: None     Source Type: Journal    
DOI: 10.4142/jvs.2007.8.4.361     Document Type: Article

References (44)

1. Alexandrov K, Rojas M, Geneste O, Castegnaro M, Camus AM, Petruzzelli S, Giuntini C, Bartsch H. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res 1992, 52, 6248-6253.
2. Arfsten DP, Schaeffer DJ, Muneny DC. The effects of near ultraviolet radiation on the toxic effects of polycyclic aromatic hydrocarbons in animals and plants: a review. Ecotoxicol Environ Saf 1996, 33, 1-24.
3. 32P-Postlabeling analysis of lipophilic DNA adducts resulting from interaction with (±)-3-hydroxy-trans-7,8-dihydroxy-9,10-epoxy-7,8,9,10- tetrahydro-benzo[a]pyrene. Chem Biol Interact 1999, 118, 87-97.
4. Bosveld ATC, de Bie PAF, van den Brink NW, Jongepier H, Klomp AV. In vitro EROD induction equivalency factor for the 10 PAHs generally monitored in risk assessment studies in the Netherlands. Chemosphere 2002, 49, 75-83.
5. Buchet JP, Gennart JP, Mercado-Calderon F, Delavignette JP, Cupers L, Lauwerys R. Evaluation of exposure to polycyclic aromatic hydrocarbons in a coke production and a graphite electrode manufacturing plant: assessment of urinary excretion of 1-hydroxypyrene as a biological indicator of exposure. Br J Ind Med 1992, 49, 761-768.
6. Buckley TJ, Loiy PJ. An examination of the time course from human dietary exposure to polycyclic aromatic hydrocarbons to urinary elimination of 1-hydroxypyrene. Br J Ind Med 1992, 49, 113-124.
7. Bulter JP, Post GB, Lioy PJ, Waldman JM, Greenberg A. Assessment of carcinogenic risk from personal exposure to benzo(a)pyrene in the total human environmental exposure study (THEES). Air Waste 1993, 43, 970-977.
8. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 1985, 34, 3337-3345.
9. Chen BH, Wang CY, Chiu CP. Evaluation of analysis of polycyclic aromatic hydrocarbons in meat products by liquid chromatography. J Agric Food Chem 1996, 44, 2244-2251.
10. Dennis MJ, Massey RC, Cripps G, Venn I, Howarth N, Lee G. Factors affecting the polycyclic aromatic hydrocarbon content of cereals, fats and other food products. Food Addit Contam 1991, 8, 517-530.
11. Easton MPL, Luszinak D, Geest EV. Preliminary examination of contaminant loadings in farmed salmon, wild salmon and commercial salmon feed. Chemosphere 2002, 46, 1053-1074.
12. Fouchecourt MO, Berny P, Riviere JL. Bioavailability of PCBs to male laboratory rats maintained on litters of contaminated soils: PCB burden and induction of alkoxyresorufin O-dealkylase activities in liver and lung. Arch Environ Contam Toxicol 1998, 35, 680-687.
13. 32P- postlabeling and HPLCFD analysis of DNA adduct in rat acutely exposed to benzo(a)pyrene. Chem Biol Interact 1997, 104, 41-54.
14. Gräslund A, Jernström B. DNA-carcinogen interaction: covalent DNA-adducts of benzo(a)pyrene 7,8-dihydrodiol-9,10-epoxides studied by biochemical and biophysical techniques. Q Rev Biophys 1989, 22, 1-37.
15. Gravato C, Santos MA. Juvenile sea bass liver P450, EROD induction, and erythrocytic genotoxic responses to PAH and PAH-like compounds. Ecotoxicol Environ Saf 2002, 51, 115-127.
16. Gündel J, Schaller KH, Angerer J. Occupational exposure to polycyclic aromatic hydrocarbons in a fireproof stone producing plant: biological monitoring of 1-hydroxypyrene, 1-, 2-, 3- and 4-hydroxyphenanthrene, 3-hydroxybenz(a)anthracene and 3-hydroxybenzo(a)pyrene. Int Arch Occup Environ Health 2000, 73, 270-274.
17. Hansen AM, Poulsen OM, Christensen JM. Determination of 1-hydroxypyrene in human urine by HPLC. J Anal Toxicol 1993, 17, 38-41.
18. IARC. IARC Monographs on the Evaluation of Carcinogenic Risk to Human. Vol. 32, p. 211, IARC, Lyon, 1983.
19. Islam GA, Greibrok T, Harvey RG, Øverebø S. HPLC analysis of benzo[a]pyrene-albumin adducts in benzo[a]pyrene exposed rats. Detection of cis-tetrols arising from hydrolysis of adducts of anti- and syn-BPDE III with proteins. Chem Biol Interact 1999, 123, 133-148.
20. Jacob J, Grimmer G. Metabolism and excretion of polycyclic aromatic hydrocarbons in rat and in human. Cent Eur J Public Health 1996, 4, 33-39.
21. Jongeneelen FJ, Akker WVD, Bos RP, Anzion RBM, Theuws JLG, Roelofs HMJ, Henderson PTH. 1-OH-pyrene as an indicator of mutagenicity of coal tar after activation with human liver preparation. Mutat Res 1988, 204, 195-201.
22. Jongeneelen FJ, Anizon RBM, Scheepers PTJ. 1-hydroxypyrene in urine as a biological indicator of exposure to polycyclic aromatic hydrocarbons in several work environments. Ann Occup Hyg 1988, 32, 35-43.
23. Jongeneelen FJ. Benchmark guideline for urinary 1- as biomarker of occupational exposure to polycyclic aromatic hydrocarbon. Ann Occup Hyg 2001, 45, 3-13.
24. Kazerouni N, Shinha R, Hsu CH, Greenberg A, Rothman N. Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol 2001, 39, 423-436.
25. Keimig SD, Kiby KW, Morgna PP. Identification of 1-hydroxypyrene as a major metabolite of pyrene in pig urine. Xenobiotica 1983, 13, 415-420.
26. Marczynski B, Rihs HP, Rossbach B, Holzer J, Angerer J, Scherenberg M, Hoffmann G, Bruning T, Wilhelm M. Analysis of 8-oxo-7,8-dihydro-2′- deoxyguanosine and DNA strand breaks in white blood cells of occupationally exposed workers: comparison with ambient monitoring, urinary metabolites and enzyme polymorphisms. Carcinogenesis 2002, 23, 273-281.
27. Mitchell CE, Tu KW. Distribution, retention, and elimination of pyrene in rats after inhalation. J Toxicol Environ Health 1979, 5, 1171-1179.
28. Moorthy B, Sriram P, Randerath K. Chemical structures and time-dependent effects of polycyclic aromatic hydrocarbon-type inducers on rat liver cytochrome P450, DNA adducts, and I-compounds. Fundamental Appl Toxicol 1994, 22, 549-560.
29. Nilsen A, Trønnes T, Westerholm R, Rannug U, Nilsen OG, Helleberg H, Kautiainen A, Hedenskog M, Törnqvist M. Short term exposure of rodent to disel exhausts; usefulness for studies of genotoxic and immunotoxic effect. Chem Biol Interact 1999, 118, 19-38.
30. Nisbet ICT, LaGoy PK. Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons. Regul Toxicol Pharmacol 1992, 16, 290-300.
31. Ovrebo S, Haugen A, Fjeldstad PE, Hemminkj K, Szyfter, K. Biological monitoring of exposure to polycyclic aromatic hydrocarbon in an electrode paste plant. J Occup Med 1994, 36, 303-310.
32. Park SS, Kim YJ, Kang CH. Atomospheric polycyclic aromatic hydrocarbons in Seoul, Korea. Atmos Environ 2002, 36, 2917-2924.
33. Parvanello S, Zanesi N, Levis AG. BaP metabolism and DNA -adduct formation in cultured human lymphocytes treated in vitro with BaP and BaP-7,8-dihydrodiol. ATLA 1992, 20, 126-137.
34. Pavanello S, Favretto D, Brugnone F, Mastrangelo G, Dal Pra G, Clonfero E. HPLC/fluorescence determination of anti-BPDE-DNA adducts in mononuclear white blood cells from PAH-exposed humans. Carcinogenesis 1999, 20, 431-435.
35. Pohl RJ, Fouts JR. A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fraction. Anal Biochem 1980, 107, 150-155.
36. Rojas M, Alexandrov K, von Schooten FS, Hillebrand M, Kriek E, Barstch H. Validation of a new fluorimetric assay for benzo[a]pyrene diolepoxide-DNA adducts in human white blood cells: comparisons with 32P-postlabeling and ELISA. Carcinogenesis 1995, 15, 557-560.
37. Roos PH, Tschirbs S, Pfeifer F, Welge P, Hack A, Wilhelm M, Bolt HM. Risk potentials for humans of original and remediated PAH-contaminated soils: application of biomarkers of effect. Toxicology 2004, 205, 181-194.
38. Roos PH, van Afferden M, Strotkamp D, Tappe D, Pfeifer F, Hanstein WG. Liver microsomal levels of cytochrome P450IA1 as biomarker for exposure and bioavailability of soil-bound polycyclic aromatic hydrocarbons. Arch Environ Contam Toxicol 1996, 30, 107-113.
39. Saunders CR, Ramesh A, Shockley DC. Modulation of neurotoxic behavior in F-344 rats by temporal disposition of benzo(a)pyrene. Toxicol Lett 2002, 129, 33-45.
40. Sjögren M, Ehrenbrg L, Rannug U. Relevance of different biological assays in assessing initiating and promoting properties of polycyclic aromatic hydrocarbons with respect to carcinogenic potency. Mutat Res 1996, 358, 97-112.
41. WHO. Evaluation of Certain Food Additives and Contaminants; Benzo(a)pyrene. WHO Food Additives Series 28. pp. 27-29, WHO, Geneva, 1998.
42. Willett KL, Wassenberg D, Lienesch L, Reichert W, Di Giulio RT. In vivo and in vitro inhibition of CYP1A-dependent activity in Fundulus heteroclitus by the polynuclear aromatic hydrocarbon fluoranthene. Toxicol Appl Pharmacol 2001, 177, 264-271.
43. Withey JR, Law FC, Endrenyi L. Pharmacokinetics and bioavailability of pyrene in the rat. J Toxicol Environ Health 1991, 32, 429-447.
44. Yamaguchi K, Near R, Shneider A, Cui H, Ju ST, Sherr DH. Fluoranthecene-induced apoptosis in murine T cell hybridomas is independent of the aromatic hydrocarbon receptor. Toxicol Appl Pharmacol 1996, 139, 144-152.